Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMINOLEVULINIC ACID Cause Application site scab? 12 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Application site scab have been filed in association with AMINOLEVULINIC ACID (AMELUZ). This represents 0.7% of all adverse event reports for AMINOLEVULINIC ACID.

12
Reports of Application site scab with AMINOLEVULINIC ACID
0.7%
of all AMINOLEVULINIC ACID reports
0
Deaths
2
Hospitalizations

How Dangerous Is Application site scab From AMINOLEVULINIC ACID?

Of the 12 reports, 2 (16.7%) required hospitalization.

Is Application site scab Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMINOLEVULINIC ACID. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does AMINOLEVULINIC ACID Cause?

Drug ineffective (293) Off label use (178) Wrong technique in product usage process (173) Erythema (144) Product quality issue (132) Poor quality product administered (124) Pain (102) Product dose omission issue (93) Application site pain (90) Application site erythema (81)

What Other Drugs Cause Application site scab?

INGENOL MEBUTATE (451) MINOXIDIL (291) SUMATRIPTAN (110) DOCOSANOL (98) BUPRENORPHINE (67) IMIQUIMOD (47) NICOTINE (45) FLUOROURACIL (43) ESTRADIOL (42) PICATO (41)

Which AMINOLEVULINIC ACID Alternatives Have Lower Application site scab Risk?

AMINOLEVULINIC ACID vs AMINOPHYLLINE AMINOLEVULINIC ACID vs AMINOSALICYLATE AMINOLEVULINIC ACID vs AMINOSALICYLIC ACID AMINOLEVULINIC ACID vs AMIODARONE AMINOLEVULINIC ACID vs AMISULPRIDE

Related Pages

AMINOLEVULINIC ACID Full Profile All Application site scab Reports All Drugs Causing Application site scab AMINOLEVULINIC ACID Demographics